38,905
Views
8
CrossRef citations to date
0
Altmetric
Review Article

D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications

, ORCID Icon, , , , & ORCID Icon show all
Pages 548-577 | Received 23 Jun 2018, Accepted 25 Sep 2018, Published online: 10 Jan 2019

References

  • Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113:2878–2887.
  • Linkins LA, Takach Lapner S. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 2017;39 (Suppl 1):98–103.
  • Riley RS, Gilbert AR, Dalton JB, et al. Widely used types and clinical applications of D-dimer assay. Lab Med. 2016;47:90–102.
  • Thachil J, Lippi G, Favaloro EJ. D-dimer testing: laboratory aspects and current issues. Methods Mol Biol. 2017;1646:91–104.
  • Blomback B. Fibrinogen and fibrin–proteins with complex roles in hemostasis and thrombosis. Thromb Res. 1996;83:1–75.
  • Sidelmann JJ, Gram J, Jespersen J, et al. Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost. 2000;26:605–618.
  • Medved L, Nieuwenhuizen W. Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb Haemost. 2003;89:409–419.
  • Gaffney PJ, Lane DA, Kakkar VV, et al. Characterisation of a soluble D dimer-E complex in crosslinked fibrin digests. Thromb Res. 1975;7:89–99.
  • Reber G, De Moerloose P. Standardization of D‐dimer testing. In: Kitchen S, Olson JD, Preston FE, editors. Quality in laboratory hemostasis and thrombosis. 2nd ed. Oxford, UK: John Wiley & Sons; 2013. p. 136–146.
  • Gaffney PJ, Edgell T, Creighton-Kempsford LJ, et al. Fibrin degradation product (FnDP) assays: analysis of standardization issues and target antigens in plasma. Br J Haematol. 1995;90:187–194.
  • Lip GY, Lowe GD. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci. 1995;89:205–214.
  • Haase C, Joergensen M, Ellervik C, et al. Age- and sex-dependent reference intervals for D-dimer: evidence for a marked increase by age. Thromb Res. 2013;132:676–680.
  • Dempfle CE. Validation, calibration, and specificity of quantitative D-dimer assays. Semin Vasc Med. 2005;5:315–320.
  • ISO. Medical laboratories— Requirements for quality and competence. ISO 15189:2012. Geneva, Switzerland: International Organization for Standardization; 2012.
  • Lippi G, Franchini M, Montagnana M, et al. Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis. 2006;17:513–519.
  • Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med. 2006;44:750–759.
  • Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem. 1997;43:1348–1351.
  • Plebani M, Favaloro EJ, Lippi G. Patient safety and quality in laboratory and hemostasis testing: a renewed loop? Semin Thromb Hemost. 2012;38:553–558.
  • Preston FE, Lippi G, Favaloro EJ, et al. Quality issues in laboratory haemostasis. Haemophilia. 2010;16:93–99.
  • Lippi G, Favaloro E. Causes of errors in medical laboratories. In: Kitchen S, Olson JD, Preston FE, editors. Quality in laboratory hemostasis and thrombosis. 2nd ed. Oxford, UK: John Wiley & Sons; 2013. p. 22–31.
  • Magnette A, Chatelain M, Chatelain B, et al. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thromb J. 2016;14:49.
  • Salvagno GL, Lippi G, Bassi A, et al. Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory. J Eval Clin Pract. 2008;14:351–353.
  • Grecu DS, Vlad DC, Dumitrascu V. Quality indicators in the preanalytical phase of testing in a stat laboratory. Lab Med. 2014;45:74–81.
  • Dikmen ZG, Pinar A, Akbiyik F. Specimen rejection in laboratory medicine: necessary for patient safety? Biochem Med. 2015;25:377–385.
  • Adcock D. Sample integrity and preanalytical variables. In: Kitchen S, Olson JD, Preston FE, editors. Quality in laboratory hemostasis and thrombosis. 2nd ed. Oxford, UK: John Wiley & Sons; 2013. p. 45–56.
  • Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press; 2001. p. 67–90.
  • de Maat MP, van Schie M, Kluft C, et al. Biological variation of hemostasis variables in thrombosis and bleeding: consequences for performance specifications. Clin Chem. 2016;62:1639–1646.
  • Favaloro EJ, Funk DM, Lippi G. Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis. Lab Med. 2012;43:1–10.
  • Hunt BJ, Parratt R, Cable M, et al. Activation of coagulation and platelets is affected by the hydrophobicity of artificial surfaces. Blood Coagul Fibrinolysis. 1997;8:223–231.
  • Loeffen R, Kleinegris MC, Loubele ST, et al. Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method. J Thromb Haemost. 2012;10:2544–2554.
  • Lippi G, Salvagno GL, Montagnana M, et al. Influence of the needle bore size used for collecting venous blood samples on routine clinical chemistry testing. Clin Chem Lab Med. 2006;44:1009–1014.
  • Lippi G, Salvagno GL, Guidi GC. No influence of a butterfly device on routine coagulation assays and D-dimer measurement. J Thromb Haemost. 2005;3:389–391.
  • Lippi G, Cervellin G, Casagranda I, et al. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med. 2014;52:621–628.
  • CLSI. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays. CLSI document H21-A5. 5th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
  • Leroy-Matheron C, Gouault-Heilmann M. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements. Thromb Res. 1994;74:399–407.
  • Gosselin RC, Janatpour K, Larkin EC, et al. Comparison of samples obtained from 3.2% sodium citrate glass and two 3.2% sodium citrate plastic blood collection tubes used in coagulation testing. Am J Clin Pathol. 2004;122:843–848.
  • Yavaş S, Ayaz S, Köse SK, et al. Influence of blood collection systems on coagulation tests. Turk J Haematol. 2012;29:367–375.
  • Oude Elferink RF, Loot AE, Van De Klashorst CG, et al. Clinical evaluation of eight different D-dimer tests for the exclusion of deep venous thrombosis in primary care patients. Scand J Clin Lab Invest. 2015;75:230–238.
  • Schutgens RE, Haas FJ, Ruven HJ, et al. No influence of heparin plasma and other (pre)analytic variables on D-dimer determinations. Clin Chem. 2002;48:1611–1613.
  • Vukovich TC, Hamwi A, Bieglmayer C. D-dimer testing within the routine clinical chemistry profile. Clin Chem. 1998;44:1557–1558.
  • Lippi G, Salvagno GL, Rossi L, et al. Analytical performances of the D-dimer assay for the Immulite 2000 automated immunoassay analyser. Int J Lab Haematol. 2007;29:415–420.
  • Lacroix R, Judicone C, Poncelet P, et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost. 2012;10:437–446.
  • Le Quellec S, Paris M, Nougier C, et al. Pre-analytical effects of pneumatic tube system transport on routine haematology and coagulation tests, global coagulation assays and platelet function assays. Thromb Res. 2017;153:7–13.
  • Wallin O, Soderberg J, Grankvist K, et al. Preanalytical effects of pneumatic tube transport on routine haematology, coagulation parameters, platelet function and global coagulation. Clin Chem Lab Med. 2008;46:1443–1449.
  • Boudaoud L, Divaret Marie G, Bezeaud PA. Rapid centrifugation for routine coagulation testing. Ann Biol Clin. 2006;64:315–317.
  • Salvagno GL, Lippi G, Montagnana M, et al. Influence of temperature and time before centrifugation of specimens for routine coagulation testing. Int J Lab Hematol. 2009;31:462–467.
  • Toulon P, Metge S, Hangard M, et al. Impact of different storage times at room temperature of unspun citrated blood samples on routine coagulation tests results. Results of a bicenter study and review of the literature. Int J Lab Hem. 2017;39:458–468.
  • Elf JL, Strandberg K, Svensson PJ. Performance of two relatively new quantitative D-dimer assays (Innovance D-dimer and AxSYM D-dimer) for the exclusion of deep vein thrombosis. Thromb Res. 2009;124:701–705.
  • Lippi G, Avanzini P, Zobbi V, et al. Influence of mechanical hemolysis of blood on two D-dimer immunoassays. Blood Coagul Fibrinolysis. 2012;23:461–463.
  • Lippi G, Blanckaert N, Bonini P, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med. 2008;46:764–772.
  • Lippi G, Plebani M, Favaloro EJ. Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost. 2012;39:258–266.
  • Lippi G, von Meyer A, Cadamuro J, et al. Blood sample quality. Diagnosis (Berl). 2018. DOI: 10.1515/dx-2018-0018.
  • Lippi G, Montagnana M, Salvagno GL, et al. Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med. 2006;130:181–184.
  • D'Angelo G, Villa C, Tamborini A, et al. Evaluation of the main coagulation tests in the presence of hemolysis in healthy subjects and patients on oral anticoagulant therapy. Int Jnl Lab Hem. 2015;37:819–833.
  • Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem. 2000;46:306–307.
  • Lippi G, Ippolito L, Tondelli MT, et al. Interference from heterophilic antibodies in D-dimer assessment. A case report. Blood Coagul Fibrinolysis. 2014;25:277–279.
  • Mugler K, Lefkowitz JB. False-positive D-dimer result in a patient with Castleman disease. Arch Pathol Lab Med. 2004;128:328–331.
  • Pittet JL, de Moerloose P, Reber G, et al. VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma. Clin Chem. 1996;42:410–415.
  • La'ulu SL, Dominguez CM, Roberts WL. Performance characteristics of the AxSYM D-dimer assay. Clin Chim Acta. 2008;390:148–151.
  • Park SJ, Chi HS, Chun SH, et al. Evaluation of performance including influence by interfering substances of the innovance D-dimer assay on the Sysmex coagulation analyzer. Clin Exp Thromb Hemost. 2018;4:11–14.
  • Chen L, Chen Y. Performance evaluation of the Sysmex CS-5100 automated coagulation analyzer. Clin Lab. 2015;61:653–660.
  • Flieder T, Gripp T, Knabbe C, et al. The Sysmex CS-5100 coagulation analyzer offers comparable analytical performance and excellent throughput capabilities. Pract Lab Med. 2016;6:38–47.
  • Huang H, Li H, Li D. Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma. Blood Coagul Fibrinolysis. 2015;26:555–559.
  • Roller RE, Lahousen T, Lipp RW, et al. Elevated D-dimer results in a healthy patient. Blood Coagul Fibrinolysis. 2001;12:501–502.
  • Wu XY, Yin YF, Teng JL, et al. IgMk paraprotein from gammopathy patient can bind to cardiolipin and interfere with coagulation assay: a case report. BMC Immunol. 2017;18:32.
  • Gardiner C, Pennaneac'h C, Mackie IJ, et al. Falsely elevated D-dimer results in a healthy patient on account of heterophiletul antibodies. Br J Haematol. 2003;122:871–873.
  • Rouviere JA, Devignes J, de Maistre E, et al. Discrepancy between two methods of D-dimers measurement: one case of human anti-mouse antibody interference. Ann Biol Clin (Paris). 2008;66:441–446.
  • Favresse J, Burlacu MC, Maiter D, et al. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr Rev. 2018;39:830–850.
  • Bohm-Weigert M, Wissel T, Muth H, et al. Long- and short-term in vitro D-dimer stability measured with innovance D-Dimer. Thromb Haemost. 2010;103:461–465.
  • Betsou F, Roussel B, Guillaume N, et al. Long-term stability of coagulation variables: protein S as a biomarker for preanalytical storage-related variations in human plasma. Thromb Haemost. 2009;101:1172–1175.
  • Foshat M, Bates S, Russo W, et al. Effect of freezing plasma at -20 degrees C for 2 weeks on prothrombin time, activated partial thromboplastin time, dilute Russell viper venom time, activated protein C resistance, and D-dimer levels. Clin Appl Thromb Hemost. 2015;21:41–47.
  • Woodhams B, Girardot O, Blanco MJ, et al. Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis. 2001;12:229–236.
  • Bastin P, Favresse J, Streel C, et al. Assessment of in vitro stability: a call for harmonization across studies. Clin Chem Lab Med. 2018;56:e121–e124.
  • Topic E, Nikolac N, Panteghini M, et al. How to assess the quality of your analytical method? Clin Chem Lab Med. 2015;53:1707–1718.
  • Zurcher M, Sulzer I, Barizzi G, et al. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost. 2008;99:416–426.
  • Kemkes-Matthes B, Fischer R, Peetz D. Influence of 8 and 24-h storage of whole blood at ambient temperature on prothrombin time, activated partial thromboplastin time, fibrinogen, thrombin time, antithrombin and D-dimer. Blood Coagul Fibrinolysis. 2011;22:215–220.
  • Rimac V, Coen Herak D. Is it acceptable to use coagulation plasma samples stored at room temperature and 4 degrees C for 24 hours for additional prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin, and D-dimer testing? Int J Lab Hem. 2017;39:475–481.
  • Zhao Y, Lv G. Influence of temperature and storage duration on measurement of activated partial thromboplastin time, D-dimers, fibrinogen, prothrombin time and thrombin time, in citrate-anticoagulated whole blood specimens. Int Jnl Lab Hem. 2013;35:566–570.
  • Caliezi C, Reber G, Lammle B, et al. Agreement of D-dimer results measured by a rapid ELISA (VIDAS) before and after storage during 24h or transportation of the original whole blood samples. Thromb Haemost. 2000;83:177–178.
  • Gosselin RC, Dwyre DW. Determining the effect of freezing on coagulation testing: comparison of results between fresh and once frozen-thawed plasma. Blood Coagul Fibrinolysis. 2015;26:69–74.
  • Rylatt DB, Blake AS, Cottis LE, et al. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res. 1983;31:767–778.
  • Greenberg CS, Devine DV, McCrae KM. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads. Am J Clin Pathol. 1987;87:94–100.
  • Lippi G, Lima-Oliveira G, Brocco G, et al. Estimating the intra- and inter-individual imprecision of manual pipetting. Clin Chem Lab Med. 2017;55:962–966.
  • Lippi G, Ippolito L, Russello T, et al. Analytical performance of the new ACL AcuStar HemosIL D-Dimer. Blood Coagul Fibrinolysis. 2012;23:164–167.
  • Salvagno GL, Lippi G, Manzato F, et al. Analytical comparison of AxSYM, HemosIL DD HS and innovance D-dimer immunoassays with the Vidas D-dimer. Int J Lab Hematol. 2009;31:475–477.
  • van der Graaf F, van den Borne H, van der Kolk M, et al . Exclusion of deep venous thrombosis with D-dimer testing-comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost. 2000;83:191–198.
  • Mountain D, Jacobs I, Haig A. The VIDAS D-dimer test for venous thromboembolism: a prospective surveillance study shows maintenance of sensitivity and specificity when used in normal clinical practice. Am J Emerg Med. 2007;25:464–471.
  • Perrier A, Desmarais S, Miron MJ, et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet. 1999;353:190–195.
  • Sidelmann JJ, Gram J, Larsen A, et al. Analytical and clinical validation of a new point-of-care testing system for determination of D-Dimer in human blood. Thromb Res. 2010;126:524–530.
  • Helmersson-Karlqvist J, Karlsson B, Fredriksson A, et al. Evaluation of the Alere D-dimer test for point of care testing. J Thromb Thrombolysis. 2014;38:250.
  • Lucassen WA, Erkens PM, Geersing GJ, et al. Qualitative point-of-care D-dimer testing compared with quantitative D-dimer testing in excluding pulmonary embolism in primary care. J Thromb Haemost. 2015;13:1004–1009.
  • Sen B, Kesteven P, Avery P. Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED). J Clin Pathol. 2014;67:437–440.
  • Marquardt U, Apau D. Point-of-care D-dimer testing in emergency departments. Emerg Nurse. 2015;23:29–35.
  • Rooney KD, Schilling UM. Point-of-care testing in the overcrowded emergency department-can it make a difference? Crit Care. 2014;18:692.
  • Geersing GJ, Toll DB, Janssen KJ, et al. Diagnostic accuracy and user-friendliness of 5 point-of-care D-dimer tests for the exclusion of deep vein thrombosis. Clin Chem. 2010;56:1758–1766.
  • Dempfle CE, Zips S, Ergul H, et al. The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer. Thromb Haemost. 2001;86:1204–1209.
  • Meijer P, Haverkate F, Kluft C, et al. A model for the harmonisation of test results of different quantitative D-dimer methods. Thromb Haemost. 2006;95:567–572.
  • Spannagl M, Haverkate F, Reinauer H, et al. The performance of quantitative D-dimer assays in laboratory routine. Blood Coagul Fibrinolysis. 2005;16:439–443.
  • Olson JD, Cunningham MT, Higgins RA, et al. D-dimer: simple test, tough problems. Arch Pathol Lab Med. 2013;137:1030–1038.
  • Jennings I, Woods TA, Kitchen DP, et al. Laboratory D-dimer measurement: improved agreement between methods through calibration. Thromb Haemost. 2007;98:1127–1135.
  • Madoiwa S, Kitajima I, Ohmori T, et al. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products. Thromb Res. 2013;132:457–464.
  • Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost. 1997;77:1031–1033.
  • Longstaff C, Adcock D, Olson JD, et al. Harmonisation of D-dimer - A call for action. Thromb Res. 2016;137:219–220.
  • Dempfle CE. D-dimer assays: the current status and new assay technologies. Thromb Res. 2006;118:569–571.
  • Lippi G, Tripodi A, Simundic AM, et al. International survey on D-dimer test reporting: a call for standardization. Semin Thromb Hemost. 2015;41:287–293.
  • Goodwin AJ, Higgins RA, Moser KA, et al. Issues surrounding age-adjusted d-dimer cutoffs that practicing physicians need to know when evaluating patients with suspected pulmonary embolism. Ann Intern Med. 2017;166:361–363.
  • Giannitsis E, Mair J, Christersson C, et al. How to use D-dimer in acute cardiovascular care. Eur Heart J Acute Cardiovasc Care. 2017;6:69–80.
  • Tripodi A, Chantarangkul V. Performance of quantitative D-dimer methods: results of the Italian external quality assessment scheme. J Thromb Haemost. 2007;5:184–185.
  • Kitchen S. Quality assurance in hemostasis. A European versus North American perspective. Lab Hematol. 2004;10:175–177.
  • Siragusa S. D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism. Int Emergency Med. 2006;1:59–66.
  • Keeling DM, Mackie IJ, Moody A, et al. The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D-dimer assays to reduce the need for diagnostic imaging. Br J Haematol. 2004;124:15–25.
  • Pernod G, Wu H, de Maistre E, et al. Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study. Blood Coagul Fibrinolysis. 2017;28:254–260.
  • Boeer K, Siegmund R, Schmidt D, et al. Comparison of six D-dimer assays for the detection of clinically suspected deep venous thrombosis of the lower extremities. Blood Coagul Fibrinolysis. 2009;20:141–145.
  • Coen Herak D, Milos M, Zadro R. Evaluation of the innovance D-DIMER analytical performance. Clin Chem Lab Med. 2009;47:945–951.
  • de Moerloose P, Palareti G, Aguilar C, et al. A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism. Thromb Haemost. 2008;100:505–512.
  • Lucassen W, Geersing GJ, Erkens PM, et al. Clinical decision rules for excluding pulmonary embolism: a meta-analysis. Ann Intern Med. 2011;155:448–460.
  • Deitelzweig SB, Johnson BH, Lin J, et al. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol. 2011;86:217–220.
  • Schouten HJ, Geersing GJ, Koek HL, et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ. 2013;346:f2492.
  • Douma RA, le Gal G, Sohne M, et al. Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts. BMJ. 2010;340:c1475.
  • Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. Jama. 2014;311:1117–1124.
  • Pernod G, Maignan M, Marlu R. Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies: comment. J Thromb Haemost. 2016;14:2553–2554.
  • Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95:362–372.
  • Szecsi PB, Jorgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103:718–727.
  • Tromeur C, van der Pol LM, Klok FA, et al. Pitfalls in the diagnostic management of pulmonary embolism in pregnancy. Thromb Res. 2017;151(Suppl 1): S86–S91.
  • Hunt BJ, Parmar K, Horspool K, et al. The DiPEP (Diagnosis of PE in Pregnancy) biomarker study: An observational cohort study augmented with additional cases to determine the diagnostic utility of biomarkers for suspected venous thromboembolism during pregnancy and puerperium. Br J Haematol. 2018;180:694–704.
  • Lippi G, Bonfanti L, Saccenti C, et al. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med. 2014;25:45–48.
  • Tripodi A. D-dimer testing in laboratory practice. Clin Chem. 2011;57:1256–1262.
  • Garcia Suquia A, Alonso-Fernandez A, de la Pena M, et al. High D-dimer levels after stopping anticoagulants in pulmonary embolism with sleep apnoea. Eur Respir J. 2015;46:1691–1700.
  • Lippi G, Mattiuzzi C, Franchini M. Sleep apnea and venous thromboembolism. A systematic review. Thromb Haemost. 2015;114:958–963.
  • Saposnik G, Barinagarrementeria F, Brown RD, Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American. Stroke Assoc. 2011;42:1158–1192.
  • Dentali F, Squizzato A, Marchesi C, et al. D-dimer testing in the diagnosis of cerebral vein thrombosis: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2012;10:582–589.
  • Alons IM, Jellema K, Wermer MJ, et al. D-dimer for the exclusion of cerebral venous thrombosis: a meta-analysis of low risk patients with isolated headache. BMC Neurol. 2015;15:118.
  • Cui JS, Jing ZP, Zhuang SJ, et al. D-dimer as a biomarker for acute aortic dissection: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e471.
  • Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121:e266–e369.
  • Suzuki T, Distante A, Zizza A, et al. Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation. 2009;119:2702–2707.
  • Shimony A, Filion KB, Mottillo S, et al. Meta-analysis of usefulness of d-dimer to diagnose acute aortic dissection. Am J Cardiol. 2011;107:1227–1234.
  • Watanabe H, Horita N, Shibata Y, et al. Diagnostic test accuracy of D-dimer for acute aortic syndrome: systematic review and meta-analysis of 22 studies with 5000 subjects. Sci Rep. 2016;6:26893.
  • Nazerian P, Morello F, Vanni S, et al. Combined use of aortic dissection detection risk score and D-dimer in the diagnostic workup of suspected acute aortic dissection. Int J Cardiol. 2014;175:78–82.
  • Rogers AM, Hermann LK, Booher AM, et al. Sensitivity of the aortic dissection detection risk score, a novel guideline-based tool for identification of acute aortic dissection at initial presentation: results from the international registry of acute aortic dissection. Circulation. 2011;123:2213–2218.
  • Fang Z, Zhu XH, Wei X, et al. The diagnostic value of combined D-dimer with other indicators in suspected acute aortic dissection patients. Int J Cardiol. 2018;268:215.
  • Nazerian P, Mueller C, Soeiro AM, et al. Diagnostic accuracy of the aortic dissection detection risk score plus d-dimer for acute aortic syndromes: the ADvISED prospective multicenter study. Circulation. 2018;137:250–258.
  • Akyildiz H, Akcan A, Ozturk A, et al. The correlation of the D-dimer test and biphasic computed tomography with mesenteric computed tomography angiography in the diagnosis of acute mesenteric ischemia. Am J Surg. 2009;197:429–433.
  • Chiu YH, Huang MK, How CK, et al. D-dimer in patients with suspected acute mesenteric ischemia. Am J Emerg Med. 2009;27:975–979.
  • Sun Y, Wang L, Wei X, et al. Analysis of a Chinese pedigree with Zellweger syndrome reveals a novel PEX1 mutation by next-generation sequencing. Clin Chim Acta. 2013;417:57–61.
  • Yang S, Fan X, Ding W, et al. D-dimer as an early marker of severity in patients with acute superior mesenteric venous thrombosis. Medicine (Baltimore). 2014;93:e270.
  • Hmoud B, Singal AK, Kamath PS. Mesenteric venous thrombosis. J Clin Exp Hepatol. 2014;4:257–263.
  • Tilsed JV, Casamassima A, Kurihara H, et al. ESTES guidelines: acute mesenteric ischaemia. Eur J Trauma Emerg Surg. 2016;42:253–270.
  • Yikilmaz A, Karahan OI, Senol S, et al. Value of multislice computed tomography in the diagnosis of acute mesenteric ischemia. Eur J Radiol. 2011;80:297–302.
  • Sun DL, Li SM, Cen YY, et al. Accuracy of using serum D-dimer for diagnosis of acute intestinal ischemia: A meta-analysis. Medicine (Baltimore). 2017;96:e6380.
  • Brotman DJ, Segal JB, Jani JT, et al. Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism. Am J Med. 2003;114:276–282.
  • Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004;140:589–602.
  • Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41:3–14.
  • Mazzolai L, Aboyans V, Ageno W, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function. Eur Heart J. 2017. DOI: 10.1093/eurheartj/ehx003.
  • Delluc A, Tromeur C, Le Ven F, et al. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France. Thromb Haemost. 2016;116:967–974.
  • Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835–1846.
  • Heit JA, Silverstein MD, Mohr DN, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159:445–453.
  • White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:I4–I8.
  • Spyropoulos AC, Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. Jmcp. 2007;13:475–486.
  • Jha AK, Larizgoitia I, Audera-Lopez C, et al. The global burden of unsafe medical care: analytic modelling of observational studies. BMJ Qual Saf. 2013;22:809–815.
  • Cohoon KP, Leibson CL, Ransom JE, et al. Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Surgery. 2015;157:423–431.
  • Cohoon KP, Leibson CL, Ransom JE, et al. Costs of venous thromboembolism associated with hospitalization for medical illness. Am J Manag Care. 2015;21:e255–e263.
  • Grosse SD. Incidence-based cost estimates require population-based incidence data. A critique of Mahan et al. Thromb Haemost. 2011;107:192–193.
  • CLSI. Quantitative D-dimer for exclusion of venous thromboembolic disease. CLSI document H59-A. Wayne, PA: Clinical and Laboratory Standard Institute; 2011.
  • Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. J Am Coll Cardiol. 2017;70:2411–2420.
  • Di Nisio M, Squizzato A, Rutjes AW, et al. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost. 2007;5:296–304.
  • Roy PM, Colombet I, Durieux P, et al. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ. 2005;331:259.
  • Carrier M, Righini M, Djurabi RK, et al. VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies. Thromb Haemost. 2009;101:886–892.
  • Mullier F, Vanpee D, Jamart J, et al. Comparison of five D-dimer reagents and application of an age-adjusted cut-off for the diagnosis of venous thromboembolism in emergency department. Blood Coagul Fibrinolysis. 2014;25:309–315.
  • Geersing GJ, Janssen KJ, Oudega R, et al. Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis. BMJ. 2009;339:b2990.
  • Chunilal SD, Eikelboom JW, Attia J, et al. Does this patient have pulmonary embolism? Jama. 2003;290:2849–2858.
  • Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. Jama. 1994;271:703–707.
  • Fagan TJ. Letter: nomogram for Bayes theorem. N Engl J Med. 1975;293:257.
  • Penaloza A, Roy PM, Kline J, et al. Performance of age-adjusted D-dimer cut-off to rule out pulmonary embolism. J Thromb Haemost. 2012;10:1291–1296.
  • Righini M, Perrier A, De Moerloose P, et al. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost. 2008;6:1059–1071.
  • Gardiner C, Pennaneac'h C, Walford C, et al. An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. Br J Haematol. 2005;128:842–848.
  • Wells PS, Hirsh J, Anderson DR, et al. A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med. 1998;243:15–23.
  • Robert-Ebadi H, Mostaguir K, Hovens MM, et al. Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score. J Thromb Haemost. 2017;15:1764–1769.
  • Spencer FA, Goldberg RJ, Lessard D, et al. Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism Study. Circ Cardiovasc Qual Outcomes. 2010;3:390.
  • Penaloza A, Verschuren F, Meyer G, et al. Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism. Ann Emerg Med. 2013;62:117–124 e2.
  • van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the years study): a prospective, multicentre, cohort study. Lancet. 2017;390:289–297.
  • Kristoffersen AH, Ajzner E, Bauca JM, et al. Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments. Thromb Res. 2017;159:19–23.
  • Kristoffersen AH, Ajzner E, Rogic D, et al. Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries. Thromb Res. 2016;142:1–7.
  • Le Gal G, Righini M, Wells PS. D-dimer for pulmonary embolism. Jama. 2015;313:1668–1669.
  • Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033–3069.
  • Linkins LA, Bates SM, Lang E, et al. Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis. Ann Intern Med. 2013;158:93–100.
  • Pasha SM, Klok FA, Snoep JD, et al. Safety of excluding acute pulmonary embolism based on an unlikely clinical probability by the Wells rule and normal D-dimer concentration: a meta-analysis. Thromb Res. 2010;125:e123–e127.
  • Roy PM, Meyer G, Vielle B, et al. Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann Intern Med. 2006;144:157–164.
  • Bates SM, Takach Lapner S, Douketis JD, et al. Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study. J Thromb Haemost. 2016;14:504–509.
  • Bates SM. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost. 2012;38:673–682.
  • Sohne M, Kamphuisen PW, van Mierlo PJ, et al. Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in- and outpatients. Thromb Haemost. 2005;94:206–210.
  • Farm M, Siddiqui A, Onelöv L, et al. Age-adjusted D-dimer cutoffs for DVT and pulmonary embolism: a comparison of five assays. Blood. 2016;128:1419–1419.
  • Prochaska JH, Frank B, Nagler M, et al. Age-related diagnostic value of D-dimer testing and the role of inflammation in patients with suspected deep vein thrombosis. Sci Rep. 2017;7:4591.
  • Raja AS, Greenberg JO, Qaseem A, et al. Evaluation of patients with suspected acute pulmonary embolism: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2015;163:701–711.
  • Solberg R, Glass G. Adjusting D-dimer cutoffs: brief literature summary and issues in clinical use. Am J Emerg Med. 2018;36:2105–2107.
  • Kabrhel C, Mark Courtney D, Camargo CA, Jr, et al. Potential impact of adjusting the threshold of the quantitative D-dimer based on pretest probability of acute pulmonary embolism. Acad Emerg Med. 2009;16:325–332.
  • Linkins LA, Bates SM, Ginsberg JS, et al. Use of different D-dimer levels to exclude venous thromboembolism depending on clinical pretest probability. J Thromb Haemost. 2004;2:1256–1260.
  • Takach Lapner S, Julian JA, Linkins LA, et al. Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism. Thromb Haemost. 2017;117:1937–1943.
  • Kline JA, Hogg MM, Courtney DM, et al. D-dimer threshold increase with pretest probability unlikely for pulmonary embolism to decrease unnecessary computerized tomographic pulmonary angiography. J Thromb Haemost. 2012;10:572–581.
  • van der Pol LM, van der Hulle T, Mairuhu ATA, et al. Combination of pulmonary embolism rule-out criteria and YEARS algorithm in a European cohort of patients with suspected pulmonary embolism. Thromb Haemost. 2018;118:547–552.
  • Desciak MC, Martin DE. Perioperative pulmonary embolism: diagnosis and anesthetic management. J Clin Anesth. 2011;23:153–165.
  • Penaloza AKC, Verschuren F, Vielle B, et al. D-dimer relevance score. J Thromb Haemost 2013;11:1–1322.
  • Wang M, Lu S, Li S, et al. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer. Clin Chim Acta. 2013;425:176–180.
  • Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem. 2005;51:825–829.
  • Kovac M, Mikovic Z, Rakicevic L, et al. The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2010;148:27–30.
  • Van der Pol LM, Mairuhu AT, Tromeur C, et al. Use of clinical prediction rules and D-dimer tests in the diagnostic management of pregnant patients with suspected acute pulmonary embolism. Blood Rev. 2017;31:31–36.
  • Leung AN, Bull TM, Jaeschke R, et al . American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline-Evaluation of Suspected Pulmonary Embolism in Pregnancy. Radiology. 2012;262:635–646.
  • Sökücü S, Gökçe S, Güllüoğlu M, et al . The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection. Scand J Infect Dis. 2010;42:699–703.
  • Geersing GJ, Zuithoff NP, Kearon C, et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ. 2014;348:g1340.
  • Carrier M, Lee AY, Bates SM, et al. Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients. Thromb Res. 2008;123:177–183.
  • Ay C, Dunkler D, Marosi C, et al. Prediction of venous thromboembolism in cancer patients. Blood. 2010;116:5377–5382.
  • Robert-Ebadi H, Bertoletti L, Combescure C, et al. Effects of impaired renal function on levels and performance of D-dimer in patients with suspected pulmonary embolism. Thromb Haemost. 2014;112:614–620.
  • Lindner G, Funk GC, Pfortmueller CA, et al. D-dimer to rule out pulmonary embolism in renal insufficiency. Am J Med. 2014;127:343–347.
  • Karami-Djurabi R, Klok FA, Kooiman J, et al. D-dimer testing in patients with suspected pulmonary embolism and impaired renal function. Am J Med. 2009;122:1050–1053.
  • Douketis J, Tosetto A, Marcucci M, et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ. 2011;342:d813.
  • Palareti G, Cosmi B, Legnani C, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006;355:1780–1789.
  • Legnani C, Palareti G, Cosmi B, et al. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. Haematologica. 2008;93:900–907.
  • Legnani C, Cini M, Cosmi B, et al. Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence. Intern Emerg Med. 2013;8:229–236.
  • Lippi G, Favaloro EJ, Cervellin G. A review of the value of D-dimer testing for prediction of recurrent venous thromboembolism with increasing age. Semin Thromb Hemost. 2014;40:634–639.
  • Verhovsek M, Douketis JD, Yi Q, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med. 2008;149:481–490.
  • Nagler M, Ten Cate H, Prins MH, et al. Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment ncorporating residual vein obstruction. Res Pract Thromb Haemost. 2018;2:299–309.
  • Baglin T, Luddington R, Brown K, et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362:523–526.
  • Tosetto A, Iorio A, Marcucci M, et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost. 2012;10:1019–1025.
  • Tosetto A, Testa S, Martinelli I, et al. External validation of the DASH prediction rule: a retrospective cohort study. J Thromb Haemost. 2017;15:1963–1970.
  • Ensor J, Riley RD, Moore D, et al. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE. BMJ Open. 2016;6:e011190.
  • Eichinger S, Heinze G, Jandeck LM, et al. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation. 2010;121:1630–1636.
  • Marcucci M, Iorio A, Douketis JD, et al. Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data. J Thromb Haemost. 2015;13:775–781.
  • Rodger MA, Le Gal G, Anderson DR, et al. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. BMJ. 2017;356:j1065.
  • Rodger MA, Kahn SR, Wells PS, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. Cmaj. 2008;179:417–426.
  • Ageno W, Squizzato A, Wells PS, et al. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost. 2013;11:1597–1602.
  • Gibson CM, Jennings LK, Chi G, et al. Association of D-dimer levels with clinical event rates and the efficacy of betrixaban versus enoxaparin in the APEX trial. TH Open. 2018;02:e16–e24.
  • Gibson C, Spyropoulos A, Cohen A, et al. The IMPROVEDD VTE risk score: incorporation of D-Dimer into the IMPROVE score to improve venous thromboembolism risk stratification. TH Open. 2017;01:e56–e65.
  • Cohen AT, Harrington R, Goldhaber SZ, et al. The design and rationale for the acute medically Ill venous thromboembolism prevention with extended duration betrixaban (APEX) study. Am Heart J. 2014;167:335–341.
  • Desjardins L, Bara L, Boutitie F, et al. Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study. Arch Pathol Lab Med. 2004;128:519–526.
  • Fan J, Li X, Cheng Y, et al. Measurement of D-dimer as aid in risk evaluation of VTE in elderly patients hospitalized for acute illness: a prospective, multicenter study in China. Cim. 2011;34:96–104.
  • Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;11:761–767.
  • Wada H, Takahashi H, Uchiyama T, et al. The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2017;15:17.
  • Hayakawa M, Gando S, Hoshino H. A Prospective comparison of new Japanese criteria for disseminated intravascular coagulation: new Japanese criteria versus ISTH criteria. Clin Appl Thromb Hemost. 2007;13:172–181.
  • Asakura H, Takahashi H, Uchiyama T, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016;14:42.
  • Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145:24–33.
  • Gris JC, Bouvier S, Cochery-Nouvellon E, et al. Fibrin-related markers in patients with septic shock: individual comparison of D-dimers and fibrin monomers impacts on prognosis. Thromb Haemost. 2011;106:1228–1230.